---
title: "First patient enrolled in EASE HF2 study of Intershunt technology for HFrEF treatment"
date: "2025-07-01T08:57:06.000Z"
publishedDate: "1 juillet 2025"
summary: "InterShunt Technologies has announced the start of the EASE HF2 early feasibility study, which is evaluating a device designed to reduce heart failure symptoms and improve quality of life. The first US procedure utilising InterShunt&#8217;s technology was performed by Sitaramesh Emani and the Structural Heart Intervention team at The Christ Hospital Health Network (Cincinnati, USA)."
importance: ""
sourceUrl: "https://cardiovascularnews.com/first-patient-enrolled-in-ease-hf2-study-of-intershunt-technology-for-hfref-treatment/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-07-01-first-patient-enrolled-in-ease-hf2-study-of-intershunt-technology-for-hfref-treatment"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2020/08/Medical-students-1024x768-1.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-patient-enrolled-in-ease-hf2-study-of-intershunt-technology-for-hfref-treatment/"
---

![First patient enrolled in EASE HF2 study of Intershunt technology for HFrEF treatment](http://cardiovascularnews.com/wp-content/uploads/sites/14/2020/08/Medical-students-1024x768-1.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-patient-enrolled-in-ease-hf2-study-of-intershunt-technology-for-hfref-treatment/*

## L’essentiel

InterShunt Technologies has announced the start of the EASE HF2 early feasibility study, which is evaluating a device designed to reduce heart failure symptoms and improve quality of life. The first US procedure utilising InterShunt&#8217;s technology was performed by Sitaramesh Emani and the Structural Heart Intervention team at The Christ Hospital Health Network (Cincinnati, USA).

## Lien source

https://cardiovascularnews.com/first-patient-enrolled-in-ease-hf2-study-of-intershunt-technology-for-hfref-treatment/
